APO RESEARCH · REPORT
Dental Drug
There are a number of different drugs that dentist may prescribe, depending on patient’s condition. Some medications are prescribed to fight certain oral diseases, to prevent or treat infections, or to control pain and relieve anxiety. The dose of the drugs and instructions on how to take them will differ from patient to patient, depending on what the drug is being used for, patient's age, weight, and other considerations.
Product & engineering
Understand the product.
There are a number of different drugs that dentist may prescribe, depending on patient’s condition. Some medications are prescribed to fight certain oral diseases, to prevent or treat infections, or to control pain and relieve anxiety. The dose of the drugs and instructions on how to take them will differ from patient to patient, depending on what the drug is being used for, patient's age, weight, and other considerations.
Selected research
Market Analysis & Forecast
Global Dental Drug Market Analysis and Forecast 2026-2032
Market perspective
There are a number of different drugs that dentist may prescribe, depending on patient’s condition. Some medications are prescribed to fight certain oral diseases, to prevent or treat infections, or to control pain and relieve anxiety. The dose of the drugs and instructions on how to take them will differ from patient to patient, depending on what the drug is being used for, patient's age, weight, and other considerations.
Global Dental Drug key players include Merck, Bayer, JandJ, GSK, 3M, etc. Global top five players hold a share about 40%.
North America is the largest market, with a share about 35%, followed by Europe and Asia-Pacific, having a total share about 55 percent.
Read the full market overview
In terms of product, OTC is the largest segment, with a share about 60%. And in terms of application, the largest application is Hospitals, followed by Dental Clinics, Drugstores.
Report Includes
This report presents an overview of global market for Dental Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Dental Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Dental Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dental Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dental Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Dental Drug revenue, projected growth trends, production technology, application and end-user industry.
Dental Drug Segment by Company
Merck
Bayer
JandJ
GSK
3M
Sunstar
Colgate-Palmolive
DenMat
Showa Yakuhin Kako
Bausch Health
Septodont
Roche
PerioChip
Hutchison China MediTech
Xiuzheng Pharmaceutical
Acteon
Xttrium Laboratorie
Mediwin Pharmaceuticals
Dental Drug Segment by Type
OTC
Prescription Product
Dental Drug Segment by Application
Hospitals
Dental Clinics
Drugstores
Dental Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dental Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dental Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dental Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Dental Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Dental Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dental Drug revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- OTC
- Prescription Product
Applications
- Hospitals
- Dental Clinics
- Drugstores
Companies covered
- Merck
- Bayer
- JandJ
- GSK
- 3M
- Sunstar
- Colgate-Palmolive
- DenMat
- Showa Yakuhin Kako
- Bausch Health
- Septodont
- Roche
- PerioChip
- Hutchison China MediTech
- Xiuzheng Pharmaceutical
- Acteon
- Xttrium Laboratorie
- Mediwin Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Dental Drug Market by Type
- 1.2.1 Global Dental Drug Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 OTC
- 1.2.3 Prescription Product
- 1.3 Dental Drug Market by Application
- 1.3.1 Global Dental Drug Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Dental Clinics
- 1.3.4 Drugstores
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Dental Drug Market Dynamics
- 2.1 Dental Drug Industry Trends
- 2.2 Dental Drug Industry Drivers
- 2.3 Dental Drug Industry Opportunities and Challenges
- 2.4 Dental Drug Industry Restraints
3 Global Growth Perspective
- 3.1 Global Dental Drug Market Perspective (2021-2032)
- 3.2 Global Dental Drug Growth Trends by Region
- 3.2.1 Global Dental Drug Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Dental Drug Market Size by Region (2021-2026)
- 3.2.3 Global Dental Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Dental Drug Revenue by Players
- 4.1.1 Global Dental Drug Revenue by Players (2021-2026)
- 4.1.2 Global Dental Drug Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Dental Drug Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Dental Drug Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Dental Drug Key Players Headquarters & Area Served
- 4.4 Global Dental Drug Players, Product Type & Application
- 4.5 Global Dental Drug Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Dental Drug Market CR5 and HHI
- 4.6.3 2025 Dental Drug Tier 1, Tier 2, and Tier 3
5 Dental Drug Market Size by Type
- 5.1 Global Dental Drug Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Dental Drug Revenue by Type (2021-2032)
- 5.3 Global Dental Drug Revenue Market Share by Type (2021-2032)
6 Dental Drug Market Size by Application
- 6.1 Global Dental Drug Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Dental Drug Revenue by Application (2021-2032)
- 6.3 Global Dental Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Merck
- 7.1.1 Merck Company Information
- 7.1.2 Merck Business Overview
- 7.1.3 Merck Dental Drug Revenue and Gross Margin (2021-2026)
- 7.1.4 Merck Dental Drug Product Portfolio
- 7.1.5 Merck Recent Developments
- 7.2 Bayer
- 7.2.1 Bayer Company Information
- 7.2.2 Bayer Business Overview
- 7.2.3 Bayer Dental Drug Revenue and Gross Margin (2021-2026)
- 7.2.4 Bayer Dental Drug Product Portfolio
- 7.2.5 Bayer Recent Developments
- 7.3 JandJ
- 7.3.1 JandJ Company Information
- 7.3.2 JandJ Business Overview
- 7.3.3 JandJ Dental Drug Revenue and Gross Margin (2021-2026)
- 7.3.4 JandJ Dental Drug Product Portfolio
- 7.3.5 JandJ Recent Developments
- 7.4 GSK
- 7.4.1 GSK Company Information
- 7.4.2 GSK Business Overview
- 7.4.3 GSK Dental Drug Revenue and Gross Margin (2021-2026)
- 7.4.4 GSK Dental Drug Product Portfolio
- 7.4.5 GSK Recent Developments
- 7.5 3M
- 7.5.1 3M Company Information
- 7.5.2 3M Business Overview
- 7.5.3 3M Dental Drug Revenue and Gross Margin (2021-2026)
- 7.5.4 3M Dental Drug Product Portfolio
- 7.5.5 3M Recent Developments
- 7.6 Sunstar
- 7.6.1 Sunstar Company Information
- 7.6.2 Sunstar Business Overview
- 7.6.3 Sunstar Dental Drug Revenue and Gross Margin (2021-2026)
- 7.6.4 Sunstar Dental Drug Product Portfolio
- 7.6.5 Sunstar Recent Developments
- 7.7 Colgate-Palmolive
- 7.7.1 Colgate-Palmolive Company Information
- 7.7.2 Colgate-Palmolive Business Overview
- 7.7.3 Colgate-Palmolive Dental Drug Revenue and Gross Margin (2021-2026)
- 7.7.4 Colgate-Palmolive Dental Drug Product Portfolio
- 7.7.5 Colgate-Palmolive Recent Developments
- 7.8 DenMat
- 7.8.1 DenMat Company Information
- 7.8.2 DenMat Business Overview
- 7.8.3 DenMat Dental Drug Revenue and Gross Margin (2021-2026)
- 7.8.4 DenMat Dental Drug Product Portfolio
- 7.8.5 DenMat Recent Developments
- 7.9 Showa Yakuhin Kako
- 7.9.1 Showa Yakuhin Kako Company Information
- 7.9.2 Showa Yakuhin Kako Business Overview
- 7.9.3 Showa Yakuhin Kako Dental Drug Revenue and Gross Margin (2021-2026)
- 7.9.4 Showa Yakuhin Kako Dental Drug Product Portfolio
- 7.9.5 Showa Yakuhin Kako Recent Developments
- 7.10 Bausch Health
- 7.10.1 Bausch Health Company Information
- 7.10.2 Bausch Health Business Overview
- 7.10.3 Bausch Health Dental Drug Revenue and Gross Margin (2021-2026)
- 7.10.4 Bausch Health Dental Drug Product Portfolio
- 7.10.5 Bausch Health Recent Developments
- 7.11 Septodont
- 7.11.1 Septodont Company Information
- 7.11.2 Septodont Business Overview
- 7.11.3 Septodont Dental Drug Revenue and Gross Margin (2021-2026)
- 7.11.4 Septodont Dental Drug Product Portfolio
- 7.11.5 Septodont Recent Developments
- 7.12 Roche
- 7.12.1 Roche Company Information
- 7.12.2 Roche Business Overview
- 7.12.3 Roche Dental Drug Revenue and Gross Margin (2021-2026)
- 7.12.4 Roche Dental Drug Product Portfolio
- 7.12.5 Roche Recent Developments
- 7.13 PerioChip
- 7.13.1 PerioChip Company Information
- 7.13.2 PerioChip Business Overview
- 7.13.3 PerioChip Dental Drug Revenue and Gross Margin (2021-2026)
- 7.13.4 PerioChip Dental Drug Product Portfolio
- 7.13.5 PerioChip Recent Developments
- 7.14 Hutchison China MediTech
- 7.14.1 Hutchison China MediTech Company Information
- 7.14.2 Hutchison China MediTech Business Overview
- 7.14.3 Hutchison China MediTech Dental Drug Revenue and Gross Margin (2021-2026)
- 7.14.4 Hutchison China MediTech Dental Drug Product Portfolio
- 7.14.5 Hutchison China MediTech Recent Developments
- 7.15 Xiuzheng Pharmaceutical
- 7.15.1 Xiuzheng Pharmaceutical Company Information
- 7.15.2 Xiuzheng Pharmaceutical Business Overview
- 7.15.3 Xiuzheng Pharmaceutical Dental Drug Revenue and Gross Margin (2021-2026)
- 7.15.4 Xiuzheng Pharmaceutical Dental Drug Product Portfolio
- 7.15.5 Xiuzheng Pharmaceutical Recent Developments
- 7.16 Acteon
- 7.16.1 Acteon Company Information
- 7.16.2 Acteon Business Overview
- 7.16.3 Acteon Dental Drug Revenue and Gross Margin (2021-2026)
- 7.16.4 Acteon Dental Drug Product Portfolio
- 7.16.5 Acteon Recent Developments
- 7.17 Xttrium Laboratorie
- 7.17.1 Xttrium Laboratorie Company Information
- 7.17.2 Xttrium Laboratorie Business Overview
- 7.17.3 Xttrium Laboratorie Dental Drug Revenue and Gross Margin (2021-2026)
- 7.17.4 Xttrium Laboratorie Dental Drug Product Portfolio
- 7.17.5 Xttrium Laboratorie Recent Developments
- 7.18 Mediwin Pharmaceuticals
- 7.18.1 Mediwin Pharmaceuticals Company Information
- 7.18.2 Mediwin Pharmaceuticals Business Overview
- 7.18.3 Mediwin Pharmaceuticals Dental Drug Revenue and Gross Margin (2021-2026)
- 7.18.4 Mediwin Pharmaceuticals Dental Drug Product Portfolio
- 7.18.5 Mediwin Pharmaceuticals Recent Developments
8 North America
- 8.1 North America Dental Drug Revenue (2021-2032)
- 8.2 North America Dental Drug Revenue by Type (2021-2032)
- 8.2.1 North America Dental Drug Revenue by Type (2021-2026)
- 8.2.2 North America Dental Drug Revenue by Type (2027-2032)
- 8.3 North America Dental Drug Revenue Share by Type (2021-2032)
- 8.4 North America Dental Drug Revenue by Application (2021-2032)
- 8.4.1 North America Dental Drug Revenue by Application (2021-2026)
- 8.4.2 North America Dental Drug Revenue by Application (2027-2032)
- 8.5 North America Dental Drug Revenue Share by Application (2021-2032)
- 8.6 North America Dental Drug Revenue by Country
- 8.6.1 North America Dental Drug Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Dental Drug Revenue by Country (2021-2026)
- 8.6.3 North America Dental Drug Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Dental Drug Revenue (2021-2032)
- 9.2 Europe Dental Drug Revenue by Type (2021-2032)
- 9.2.1 Europe Dental Drug Revenue by Type (2021-2026)
- 9.2.2 Europe Dental Drug Revenue by Type (2027-2032)
- 9.3 Europe Dental Drug Revenue Share by Type (2021-2032)
- 9.4 Europe Dental Drug Revenue by Application (2021-2032)
- 9.4.1 Europe Dental Drug Revenue by Application (2021-2026)
- 9.4.2 Europe Dental Drug Revenue by Application (2027-2032)
- 9.5 Europe Dental Drug Revenue Share by Application (2021-2032)
- 9.6 Europe Dental Drug Revenue by Country
- 9.6.1 Europe Dental Drug Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Dental Drug Revenue by Country (2021-2026)
- 9.6.3 Europe Dental Drug Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Dental Drug Revenue (2021-2032)
- 10.2 China Dental Drug Revenue by Type (2021-2032)
- 10.2.1 China Dental Drug Revenue by Type (2021-2026)
- 10.2.2 China Dental Drug Revenue by Type (2027-2032)
- 10.3 China Dental Drug Revenue Share by Type (2021-2032)
- 10.4 China Dental Drug Revenue by Application (2021-2032)
- 10.4.1 China Dental Drug Revenue by Application (2021-2026)
- 10.4.2 China Dental Drug Revenue by Application (2027-2032)
- 10.5 China Dental Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Dental Drug Revenue (2021-2032)
- 11.2 Asia Dental Drug Revenue by Type (2021-2032)
- 11.2.1 Asia Dental Drug Revenue by Type (2021-2026)
- 11.2.2 Asia Dental Drug Revenue by Type (2027-2032)
- 11.3 Asia Dental Drug Revenue Share by Type (2021-2032)
- 11.4 Asia Dental Drug Revenue by Application (2021-2032)
- 11.4.1 Asia Dental Drug Revenue by Application (2021-2026)
- 11.4.2 Asia Dental Drug Revenue by Application (2027-2032)
- 11.5 Asia Dental Drug Revenue Share by Application (2021-2032)
- 11.6 Asia Dental Drug Revenue by Country
- 11.6.1 Asia Dental Drug Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Dental Drug Revenue by Country (2021-2026)
- 11.6.3 Asia Dental Drug Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Dental Drug Revenue (2021-2032)
- 12.2 SAMEA Dental Drug Revenue by Type (2021-2032)
- 12.2.1 SAMEA Dental Drug Revenue by Type (2021-2026)
- 12.2.2 SAMEA Dental Drug Revenue by Type (2027-2032)
- 12.3 SAMEA Dental Drug Revenue Share by Type (2021-2032)
- 12.4 SAMEA Dental Drug Revenue by Application (2021-2032)
- 12.4.1 SAMEA Dental Drug Revenue by Application (2021-2026)
- 12.4.2 SAMEA Dental Drug Revenue by Application (2027-2032)
- 12.5 SAMEA Dental Drug Revenue Share by Application (2021-2032)
- 12.6 SAMEA Dental Drug Revenue by Country
- 12.6.1 SAMEA Dental Drug Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Dental Drug Revenue by Country (2021-2026)
- 12.6.3 SAMEA Dental Drug Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst